Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Medical Nanotechnology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Parasite Immunol. 2024 Jan;46(1):e13018. doi: 10.1111/pim.13018. Epub 2023 Nov 21.
Inducing long-term immunity is the primary goal of vaccination. Leishmanisation using non-pathogenic to human Leishmania spp. could be considered a reliable approach to immunising subjects against Leishmania infection. Here, we evaluated the long-term immune responses (14 weeks) after immunisation with either live- or killed-Iranian Lizard Leishmania (ILL) mixed with chitin microparticles (CMPs) against L. major infection in BALB/c mice. In total, nine groups of mice were included in the study. To evaluate short-term immunity, mice were immunised with live-ILL and CMPs and 3 weeks later were challenged with L. major . To evaluate the long-term immunity, mice were immunised with either live- or killed-ILL both mixed with CMPs, and 14 weeks after immunisation, mice were challenged with L. major . A group of healthy mice who received no injection was also included in the study. Eight weeks after the challenge with L. major , all subjects were sacrificed and the parasite burden (quantitative real-time PCR and in vivo imaging), cytokines levels (IFN-γ, IL-4 and IL-10), Leishmania-specific antibody concentration, and total levels of IgG1 and IgG2a were measured. In addition, nitric oxide concentration and arginase activity were evaluated. Results showed that in mice that were immunised using live-ILL+CMP, the induced protective immune response lasted at least 14 weeks; since they were challenged with L. major at the 14 -week post-immunisation, no open lesion was formed during the 8-week follow-up, and the footpad swelling was significantly lower than controls. They also showed a significant reduction in the parasite burden in splenocytes, compared to the control groups including the group that received killed-ILL+CMP. The observed protection was associated with a higher IFN-γ and a lower IL-10 production by splenocytes. Additionally, the results demonstrated that arginase activity was decreased in the ILL+CMP group compared to other groups. Immunisation with ILL alone reduced the parasite burden compared to non-immunised control; however, it was still significantly higher than the parasite burden in the ILL+CMP groups. In conclusion, the long-term immune response against L. major infection induced by Live-ILL+CMP was more competent than the response elicited by killed-ILL+CMP to protect mice against infection with L. major .
诱导长期免疫是疫苗接种的主要目标。使用对人类无致病性的 Leishmania spp. 进行 Leishmanisation 可以被认为是一种可靠的方法,可使受试者对 Leishmania 感染产生免疫。在这里,我们评估了用活的或灭活的伊朗蜥蜴利什曼原虫(ILL)与壳聚糖微粒(CMP)混合免疫 BALB/c 小鼠后 14 周的长期免疫反应(14 周)对 L. major 感染的免疫。总共有 9 组小鼠纳入研究。为了评估短期免疫,用活的 ILL 和 CMP 免疫小鼠,3 周后用 L. major 攻毒。为了评估长期免疫,用活的或灭活的 ILL 与 CMP 混合免疫小鼠,免疫后 14 周,用 L. major 攻毒。还包括一组未注射的健康小鼠作为对照。用 L. major 攻毒 8 周后,处死所有实验动物,测量寄生虫负荷(实时定量 PCR 和体内成像)、细胞因子水平(IFN-γ、IL-4 和 IL-10)、利什曼原虫特异性抗体浓度、总 IgG1 和 IgG2a 水平。此外,还评估了一氧化氮浓度和精氨酸酶活性。结果表明,用活的 ILL+CMP 免疫的小鼠诱导的保护性免疫反应至少持续 14 周;由于它们在免疫后 14 周用 L. major 攻毒,在 8 周的随访期间没有形成开放性病变,并且足垫肿胀明显低于对照组。与包括接受灭活 ILL+CMP 的对照组相比,它们的脾细胞寄生虫负荷也显著降低。观察到的保护作用与脾细胞 IFN-γ产生增加和 IL-10 产生减少有关。此外,结果表明,与其他组相比,ILL+CMP 组的精氨酸酶活性降低。单独用 ILL 免疫可降低寄生虫负荷,与未免疫对照组相比,但仍明显高于 ILL+CMP 组。总之,用活的 ILL+CMP 诱导的针对 L. major 感染的长期免疫反应比用灭活的 ILL+CMP 诱导的反应更有效,能更有效地保护小鼠免受 L. major 感染。